AKAP9 is a genetic modifier of congenital long-QT syndrome type 1

Circulation: Cardiovascular Genetics

Volumn 7, Issue 5, 2014, Pages 599-606

  De Villiers, Carin P ^a   Van Der Merwe, Lize ^a,b   Crotti, Lia ^c,d,e   Goosen, Althea ^a   George, Alfred L ^f   Schwartz, Peter J ^c   Brink, Paul A ^a   Moolman Smook, Johanna C ^a   Corfield, Valerie A ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AKAP9; Arrhythmia; KCNQ1; Long QT syndrome

Indexed keywords

ADULT; AGE; AKAP9 GENE; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONFOUNDING VARIABLE; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; GENOTYPE; HAPLOTYPE; HEART RATE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KCNQ1 GENE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICAN; ADOLESCENT; BIOLOGICAL MODEL; CYTOLOGY; FOUNDER EFFECT; GENETIC PREDISPOSITION; GENETICS; LEUKOCYTE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; ROMANO-WARD SYNDROME; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; YOUNG ADULT;

AKAP9 PROTEIN, HUMAN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYTOSKELETON PROTEIN;

A KINASE ANCHOR PROTEINS; ADOLESCENT; ADULT; ALLELES; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; FOUNDER EFFECT; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MODELS, GENETIC; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; ROMANO-WARD SYNDROME; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; YOUNG ADULT;

EID: 84921657690     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000580     Document Type: Article

References (47)

1. Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5:868-877
2. Hedley PL, Jørgensen P, Schlamowitz S, Wangari R, Moolman-Smook J, Brink PA, et al. The genetic basis of long QT and short QT syndromes: A mutation update. Hum Mutat. 2009;30:1486-1511
3. Schwartz PJ, Ackerman MJ, George AL Jr, Wilde AA. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol. 2013;62:169-180
4. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866-1874
5. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95
6. Brink PA, Crotti L, Corfield V, Goosen A, Durrheim G, Hedley P, et al. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation. 2005;112:2602-2610
7. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99:529-533
8. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327:846-852
9. Crotti L, Monti MC, Insolia R, Peljto A, Goosen A, Brink PA, et al. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation. 2009;120:1657-1663
10. Giudicessi JR, Ackerman MJ. Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl Res. 2013;161:1-14
11. George AL Jr. Common genetic variants in sudden cardiac death. Heart Rhythm. 2009;6(11 Suppl):S3-S9
12. Kolder IC, Tanck MW, Bezzina CR. Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. J Mol Cell Cardiol. 2012;52:620-629
13. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 2002;295:496-499
14. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 1996;384:78-80
15. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996;384:80-83
16. Chen L, Kurokawa J, Kass RS. Phosphorylation of the A-kinase-anchoring protein Yotiao contributes to protein kinase A regulation of a heart potassium channel. J Biol Chem. 2005;280:31347-31352
17. Kurokawa J, Motoike HK, Rao J, Kass RS. Regulatory actions of the A-kinase anchoring protein Yotiao on a heart potassium channel downstream of PKA phosphorylation. Proc Natl Acad Sci U S A. 2004;101:16374-16378
18. Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A. 2007;104:20990-20995
19. de Jager T, Corbett CH, Badenhorst JC, Brink PA, Corfield VA. Evidence of a long QT founder gene with varying phenotypic expression in South African families. J Med Genet. 1996;33:567-573
20. Hedley PL, Durrheim GA, Hendricks F, Goosen A, Jespersgaard C, Støvring B, et al. Long QT syndrome in South Africa: The results of comprehensive genetic screening. Cardiovasc J Afr. 2013;24:231-237
21. Corfield VA, Moolman JC, Martell R, Brink PA. Polymerase chain reaction-based detection of MN blood group-specific sequences in the human genome. Transfusion. 1993;33:119-124
22. Bazett HC. An analysis of time relations of electrocardiograms. Heart. 1920;7:353-370
23. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217-1223
24. Wigginton JE, Abecasis GR. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics. 2005;21:3445-3447
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265
26. Sobel E, Lange K. Descent graphs in pedigree analysis: Applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet. 1996;58:1323-1337
27. Campbell H, Rudan I. Interpretation of genetic association studies in complex disease. Pharmacogenomics J. 2002;2:349-360
28. Balding DJ, Bishop M, Cannings C, eds. Handbook of Statistical Genetics. New York, NY: John Wiley & Sons; 2007: 927.
29. Crotti L, Spazzolini C, Schwartz PJ, Shimizu W, Denjoy I, Schulze-Bahr E, et al. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: Toward a mutation-specific risk stratification. Circulation. 2007;116:2366-2375
30. Heijman J, Spätjens RL, Seyen SR, Lentink V, Kuijpers HJ, Boulet IR, et al. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1. Circ Res. 2012;110:211-219
31. Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: Implications for mutation-specific response to ß-blocker therapy in type 1 long-QT syndrome. Circulation. 2012;125:1988-1996
32. Aydin A, Bähring S, Dahm S, Guenther UP, Uhlmann R, Busjahn A, et al. Single nucleotide polymorphism map of five long-QT genes. J Mol Med (Berl). 2005;83:159-165
33. Sedlacek K, Stark K, Cunha SR, Pfeufer A, Weber S, Berger I, et al. Common genetic variants in ANK2 modulate QT interval: Results from the KORA study. Circ Cardiovasc Genet. 2008;1:93-99
34. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet. 2009;41:399-406
35. Pfeufer A, Sanna S, Arking DE, Müller M, Gateva V, Fuchsberger C, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet. 2009;41:407-414
36. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet. 2006;38:644-651
37. Eijgelsheim M, Newton-Cheh C, Aarnoudse AL, van Noord C, Witteman JC, Hofman A, et al. Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study. Hum Mol Genet. 2009;18:4213-4218
38. Tobin MD, Kähönen M, Braund P, Nieminen T, Hajat C, Tomaszewski M, et al. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations. Int J Epidemiol. 2008;37:1132-1141
39. Arking DE, Khera A, Xing C, Kao WH, Post W, Boerwinkle E, et al. Multiple independent genetic factors at NOS1AP modulate the QT interval in a multi-ethnic population. PLoS One. 2009;4:e4333
40. Tomás M, Napolitano C, De Giuli L, Bloise R, Subirana I, Malovini A, et al. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J Am Coll Cardiol. 2010;55:2745-2752
41. Jamshidi Y, Nolte IM, Spector TD, Snieder H. Novel genes for QTc interval. How much heritability is explained, and how much is left to find? Genome Med. 2010;2:35
42. Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, et al. Risk for life-threatening cardiac events in patients with genotypeconfirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol. 2011;57:51-59
43. Terrenoire C, Houslay MD, Baillie GS, Kass RS. The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3. J Biol Chem. 2009;284:9140-9146
44. Li Y, Chen L, Kass RS, Dessauer CW. The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart. J Biol Chem. 2012;287:29815-29824
45. Kao WH, Arking DE, Post W, Rea TD, Sotoodehnia N, Prineas RJ, et al. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation. 2009;119:940-951
46. Duchatelet S, Crotti L, Peat RA, Denjoy I, Itoh H, Berthet M, et al. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. Circ Cardiovasc Genet. 2013;6:354-361
47. Schwartz PJ. Sudden cardiac death, founder populations, and mushrooms: what is the link with gold mines and modifier genes? Heart Rhythm. 2011;8:548-550.